Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › Infectious Disease

Infectious Disease (19 companies · 19 conditions)

Conditions

Hepatitis B 5 COVID-19 4 Influenza 3 HIV 2 Pneumococcal Pneumonia 2 RSV 2 BK Virus Infection 1 Rare Cholera 1 Chronic Hepatitis Delta 1 Rare Community-Acquired Pneumonia 1 Cytomegalovirus Infection 1 Group A Streptococcal Infection 1 Hepatitis C 1 Invasive Fungal Infection 1 Invasive Pneumococcal Disease 1 Leishmaniasis 1 Shigellosis 1 Surgical Site Infection 1 Vulvovaginal Candidiasis 1

Companies

Ticker Company Therapeutic areas In Infectious Disease Lead stage Programs
ADMA Adma Biologics ImmunologyInfectious Disease Rare 2 Approved 4
BCRX Biocryst Pharmaceuticals DermatologyImmunology+1 Rare 1 Approved 4
CAPR Capricor Therapeutics Infectious DiseaseNeurology Rare 1 NDA Submitted 2
ENTA Enanta Pharmaceuticals DermatologyImmunology+1 5 Approved 7
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+2 Rare 1 Approved 14
FBIO Fortress Biotech DermatologyHematology+3 Rare 1 Approved 12
IBRX ImmunityBio Infectious DiseaseOncology 1 Approved 16
IMCR Immunocore DermatologyInfectious Disease+2 2 Approved 11
IVVD Invivyd Infectious Disease 3 Approved 4
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 1 Approved 29
OCGN Ocugen Infectious DiseaseOphthalmology Rare 4 Phase 3 12
PYPD PolyPid Infectious DiseaseOncology 1 NDA Submitted 2
DTIL Precision Biosciences Infectious DiseaseMetabolic+1 Rare 1 Phase 1 5
SCYX Scynexis Infectious DiseaseRenal Rare 4 Approved 5
TTRX Turn Therapeutics DermatologyInfectious Disease Rare 1 Phase 2 4
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved 27
PCVX Vaxcyte Infectious Disease 6 Phase 3 6
VERA Vera Therapeutics Infectious DiseaseRenal Rare 1 Approved 6
VIR Vir Biotechnology Infectious DiseaseOncology Rare 2 Phase 3 10